Zhejiang Haisen Pharmaceutical Co., Ltd. (SHE:001367)
25.92
-0.50 (-1.89%)
At close: Apr 15, 2026
SHE:001367 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 909.49 | 1,034 | 943.75 | 247.19 | 205.26 |
Trading Asset Securities | 151.7 | - | - | - | 0.74 |
Cash & Short-Term Investments | 1,061 | 1,034 | 943.75 | 247.19 | 206 |
Cash Growth | 2.58% | 9.61% | 281.79% | 19.99% | 47.24% |
Accounts Receivable | 103.38 | 89.2 | 57.73 | 47.3 | 44.61 |
Other Receivables | 5.35 | 15.17 | 14.94 | 0.04 | 2.81 |
Receivables | 108.73 | 104.38 | 72.67 | 47.34 | 47.42 |
Inventory | 108.47 | 115.48 | 159.31 | 142.65 | 104.94 |
Other Current Assets | 2.45 | 3.29 | 2.25 | 9.01 | 2.39 |
Total Current Assets | 1,281 | 1,258 | 1,178 | 446.19 | 360.75 |
Property, Plant & Equipment | 224.97 | 201.51 | 134.9 | 85.64 | 85.89 |
Other Intangible Assets | 117.82 | 20.14 | 19.78 | 19.74 | 20.26 |
Long-Term Deferred Tax Assets | - | - | - | 1.79 | 1.37 |
Long-Term Deferred Charges | 0.21 | 0.27 | 0.26 | 1.8 | 3.27 |
Other Long-Term Assets | 6.42 | 6.45 | 8.04 | 10.45 | 5.76 |
Total Assets | 1,630 | 1,486 | 1,341 | 565.6 | 477.31 |
Accounts Payable | 44.88 | 52.16 | 46.55 | 34.94 | 56.28 |
Accrued Expenses | 23.72 | 18.21 | 15.65 | 14.73 | 14.97 |
Current Portion of Leases | 1.33 | 1.14 | 0.07 | 0.78 | 0.75 |
Current Income Taxes Payable | 13.83 | 9.58 | 6.05 | 21.61 | 11.33 |
Current Unearned Revenue | 3.85 | 7.92 | 4.16 | 7.08 | 9.49 |
Other Current Liabilities | 28.69 | 33.04 | 6.3 | 4.26 | 10.04 |
Total Current Liabilities | 116.3 | 122.04 | 78.77 | 83.4 | 102.86 |
Long-Term Leases | 6.1 | 6.98 | 0.1 | - | 0.78 |
Long-Term Unearned Revenue | 4.79 | 5.39 | 5.85 | 6.22 | 5.59 |
Long-Term Deferred Tax Liabilities | 9.29 | 7.43 | 6.89 | 6.7 | 6.78 |
Other Long-Term Liabilities | - | - | - | 0.24 | - |
Total Liabilities | 136.48 | 141.84 | 91.62 | 96.57 | 116.02 |
Common Stock | 152.35 | 102.65 | 68 | 51 | 51 |
Additional Paid-In Capital | 734.83 | 759.97 | 763.02 | 104.3 | 104.3 |
Retained Earnings | 624.05 | 505.63 | 417.07 | 312.4 | 204.88 |
Treasury Stock | -18.86 | -25.46 | - | - | - |
Comprehensive Income & Other | 1.38 | 1.37 | 1.25 | 1.33 | 1.11 |
Shareholders' Equity | 1,494 | 1,344 | 1,249 | 469.03 | 361.29 |
Total Liabilities & Equity | 1,630 | 1,486 | 1,341 | 565.6 | 477.31 |
Total Debt | 7.43 | 8.12 | 0.17 | 0.78 | 1.53 |
Net Cash (Debt) | 1,054 | 1,026 | 943.59 | 246.41 | 204.47 |
Net Cash Growth | 2.67% | 8.77% | 282.94% | 20.51% | 46.15% |
Net Cash Per Share | 6.90 | 6.87 | 6.88 | 2.21 | 1.83 |
Filing Date Shares Outstanding | 148.75 | 148.95 | 148.95 | 111.71 | 111.71 |
Total Common Shares Outstanding | 148.75 | 148.95 | 148.95 | 111.71 | 111.71 |
Working Capital | 1,165 | 1,136 | 1,099 | 362.78 | 257.89 |
Book Value Per Share | 10.04 | 9.02 | 8.39 | 4.20 | 3.23 |
Tangible Book Value | 1,376 | 1,324 | 1,230 | 449.29 | 341.03 |
Tangible Book Value Per Share | 9.25 | 8.89 | 8.25 | 4.02 | 3.05 |
Buildings | 104.42 | 59.66 | 55.1 | 52.99 | 53.03 |
Machinery | 199.4 | 149.06 | 123.92 | 107.08 | 106.47 |
Construction In Progress | 21.36 | 73.59 | 48.05 | 8.41 | 0.93 |
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.